|
|
|
Insider
Information: |
Schimmel Paul |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,717,702 |
|
Indirect Shares
|
1,312,785 |
|
|
Direct
Value |
$100,031,509 |
|
|
Indirect Value
|
$46,568,243 |
|
|
Total
Shares |
3,030,487 |
|
|
Total
Value |
$146,599,752 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RGEN |
Repligen Corp |
Director |
|
2005-11-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,576 |
658,106 |
|
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-09-04 |
4 |
B |
$0.76 |
$15,709 |
I/I |
20,749 |
735,077 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-08-31 |
4 |
B |
$0.72 |
$15,752 |
I/I |
22,000 |
714,328 |
2.1 |
- |
|
FBRX |
Forte Biosciences Inc |
Director |
|
2017-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
23,464 |
23,464 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-05 |
4 |
B |
$3.52 |
$88,118 |
D/D |
25,000 |
37,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-06 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
62,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-11 |
4/A |
B |
$3.45 |
$97,643 |
I/I |
27,400 |
233,581 |
2.1 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2018-03-13 |
4 |
OE |
$30.09 |
$1,369,927 |
D/D |
27,823 |
27,823 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2018-03-13 |
4 |
AS |
$150.00 |
$4,173,450 |
D/D |
(27,823) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2009-09-04 |
4 |
S |
$22.02 |
$647,482 |
D/D |
(29,400) |
204,688 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2009-09-09 |
4 |
S |
$22.10 |
$662,931 |
D/D |
(30,000) |
174,688 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,578 |
237,893 |
|
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-14 |
4 |
B |
$4.14 |
$135,075 |
D/D |
32,600 |
53,012 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-11 |
4 |
B |
$3.45 |
$116,535 |
D/D |
32,659 |
220,231 |
2.39 |
- |
|
AVCE |
Avicena Group, Inc. |
Director |
|
2005-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
33,242 |
1,205,242 |
|
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-14 |
4 |
B |
$4.22 |
$141,859 |
I/I |
33,619 |
283,581 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-07 |
4 |
B |
$3.19 |
$127,584 |
D/D |
40,000 |
102,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-12-15 |
4 |
B |
$2.50 |
$99,912 |
I/I |
40,000 |
686,814 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-05-18 |
4 |
B |
$3.98 |
$199,000 |
I/I |
50,000 |
113,023 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-08-29 |
4 |
B |
$0.72 |
$54,090 |
I/I |
75,136 |
603,053 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-08 |
4 |
B |
$3.22 |
$273,649 |
D/D |
85,000 |
187,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-08-30 |
4 |
B |
$0.76 |
$67,483 |
I/I |
89,275 |
692,328 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2017-08-31 |
4 |
B |
$2.65 |
$249,990 |
I/I |
94,336 |
377,917 |
2.1 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
officerTitle |
|
2006-01-31 |
4 |
B |
$13.00 |
$1,300,000 |
I/I |
100,000 |
338,088 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-11-26 |
4 |
B |
$0.54 |
$79,796 |
I/I |
147,225 |
882,302 |
2.1 |
- |
|
84 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|